Journey Medical Corporation – NASDAQ:DERM
Founder-led company
Journey Medical stock price today
$7.07
+2.90
+69.54%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 3 hours
Journey Medical stock price monthly change
-26.32%
month
Journey Medical stock price quarterly change
-26.32%
quarter
Journey Medical stock price yearly change
-40.77%
year
Journey Medical key metrics
Market Cap | 97.76M |
Enterprise value | N/A |
P/E | -0.9 |
EV/Sales | -0.01 |
EV/EBITDA | 0.07 |
Price/Sales | 0.23 |
Price/Book | 1.56 |
PEG ratio | -0.02 |
EPS | -0.19 |
Revenue | 79.99M |
EBITDA | 2.30M |
Income | -4.15M |
Revenue Q/Q | 6.68% |
Revenue Y/Y | 27.82% |
Profit margin | -33.43% |
Oper. margin | -30.84% |
Gross margin | 59.56% |
EBIT margin | -30.84% |
EBITDA margin | 2.88% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeJourney Medical stock price history
Journey Medical stock forecast
Journey Medical financial statements
| Jun 2023 | 17.17M | -8.36M | -48.7% |
|---|---|---|---|
| Sep 2023 | 34.53M | 16.78M | 48.61% |
| Dec 2023 | 15.25M | -2.14M | -14.05% |
| Mar 2024 | 13.03M | -10.44M | -80.14% |
| Dec 2023 | 15.25M | -2.14M | -14.05% |
|---|---|---|---|
| Mar 2024 | 13.03M | -10.44M | -80.14% |
| Oct 2025 | 28.7M | 4.74M | 16.52% |
| Dec 2025 | 35M | 7.50M | 21.45% |
Analysts Price target
Financials & Ratios estimates
| 2022-11-10 | -0.81909 | -0.57 |
|---|---|---|
| 2023-03-29 | -0.77142 | -0.6 |
| Jun 2023 | 69747000 | 69.74M | 99.99% |
|---|---|---|---|
| Sep 2023 | 65918000 | 48.54M | 73.64% |
| Dec 2023 | 76849000 | 56.49M | 73.52% |
| Mar 2024 | 66571000 | 53.62M | 80.55% |
| Jun 2023 | 3.96M | 0 | -13.08M |
|---|---|---|---|
| Sep 2023 | 18.74M | 0 | -10.97M |
| Dec 2023 | -16.42M | 5M | 19.11M |
| Mar 2024 | -5.01M | 0 | 1.63M |
Journey Medical alternative data
| Aug 2023 | 20 |
|---|---|
| Sep 2023 | 20 |
| Oct 2023 | 20 |
| Nov 2023 | 20 |
| Dec 2023 | 20 |
| Jan 2024 | 20 |
| Feb 2024 | 20 |
| Mar 2024 | 20 |
| Apr 2024 | 20 |
| May 2024 | 41 |
| Jun 2024 | 41 |
| Jul 2024 | 41 |
Journey Medical other data
16.14%
-1.63%
of DERM is owned by hedge funds
1.64M
+16.79K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 0 | 44377 |
| Jul 2023 | 0 | 24839 |
| Sep 2023 | 156044 | 0 |
| Oct 2023 | 48000 | 0 |
| Nov 2023 | 0 | 1745 |
| Feb 2024 | 0 | 2450 |
| Mar 2024 | 70000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | ROSENWALD LINDSAY A MD director | Common Stock, $0.0001 par value | 10,000 | $3.04 | $30,400 | ||
Purchase | ROSENWALD LINDSAY A MD director | Common Stock, $0.0001 par value | 10,000 | $3.04 | $30,400 | ||
Purchase | MARAOUI CLAUDE director, officer: President & .. | Common Stock, $0.0001 par value | 10,000 | $3.48 | $34,790 | ||
Purchase | SMITH JUSTIN ADAM director | Common Stock, $0.0001 par value | 30,000 | $3.47 | $104,100 | ||
Purchase | ROSENWALD LINDSAY A MD director | Common Stock, $0.0001 par value | 20,000 | $3.4 | $68,000 | ||
Purchase | ROSENWALD LINDSAY A MD director | Common Stock, $0.0001 par value | 20,000 | $3.4 | $68,000 | ||
Sale | BENESCH JOSEPH officer: Interim CFO | Common Stock, $0.0001 par value | 2,450 | $3.75 | $9,188 | ||
Sale | PALEY JEFFREY director | Common Stock, par value $0.0001 per share | 1,745 | $5.22 | $9,109 | ||
Purchase | SMITH JUSTIN ADAM director | Common Stock, par value $0.0001 per share | 33,000 | $2.98 | $98,340 | ||
Purchase | PALEY JEFFREY director | Common Stock, par value $0.0001 per share | 15,000 | $2.98 | $44,700 |
| Quarter | Transcript |
|---|---|
| Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
| Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 22 May 2023 | Q1 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Claude Maraoui (1966) Founder, Pres, Chief Executive Officer & Director | $900,830 |
-
What's the price of Journey Medical stock today?
One share of Journey Medical stock can currently be purchased for approximately $7.07.
-
When is Journey Medical's next earnings date?
Unfortunately, Journey Medical's (DERM) next earnings date is currently unknown.
-
Does Journey Medical pay dividends?
No, Journey Medical does not pay dividends.
-
How much money does Journey Medical make?
Journey Medical has a market capitalization of 97.76M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 7.48% to 79.18M US dollars. Journey Medical made a loss 3.85M US dollars in net income (profit) last year or -$0.6 on an earnings per share basis.
-
What is Journey Medical's stock symbol?
Journey Medical Corporation is traded on the NASDAQ under the ticker symbol "DERM".
-
What is Journey Medical's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Journey Medical?
Shares of Journey Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Journey Medical's key executives?
Journey Medical's management team includes the following people:
- Mr. Claude Maraoui Founder, Pres, Chief Executive Officer & Director(age: 59, pay: $900,830)
-
Is Journey Medical founder-led company?
Yes, Journey Medical is a company led by its founder Mr. Claude Maraoui.
-
How many employees does Journey Medical have?
As Jul 2024, Journey Medical employs 41 workers, which is 105% more then previous quarter.
-
When Journey Medical went public?
Journey Medical Corporation is publicly traded company for more then 3 years since IPO on 12 Nov 2021.
-
What is Journey Medical's official website?
The official website for Journey Medical is journeymedicalcorp.com.
-
Where are Journey Medical's headquarters?
Journey Medical is headquartered at 9237 East Via de Ventura Boulevard, Scottsdale, AZ.
-
How can i contact Journey Medical?
Journey Medical's mailing address is 9237 East Via de Ventura Boulevard, Scottsdale, AZ and company can be reached via phone at +48 04346670.
Journey Medical company profile:
Journey Medical Corporation
journeymedicalcorp.comExchange:
NASDAQ
Full time employees:
41
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
9237 East Via de Ventura Boulevard
Scottsdale, AZ 85258
Scottsdale, AZ 85258
CIK: 0001867066
ISIN: US48115J1097
CUSIP: 48115J109
